\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ \\-\\ vitals\\:\\ stable\\.\ \(0\)\
\-\ gen\\:\\ well\\ developed\\ \\-\\ non\\ toxic\\ appearing\\ female\\ who\\ appears\\ older\\ than\\ her\\ stated\\ age\\.\ \(0\)\
\-\ neuro\\:\\ non\\ focal\\ with\\ a\\ mild\\ resting\\ tremor\\.\ \(0\)\
\-\ labs\\:\\ ca\\+\\+\\ and\\ p\\ reported\\ normal\\ over\\ the\\ past\\ three\\ years\ \(0\)\
\-\ treatment\\:\ \(3\)\
\-\ may\\ include\\ chelators\\.\ \(0\)\
\-\ antioxidants\\.\ \(0\)\
\-\ calcium\\ antagonists\\.\ \(0\)\
\-\ non\\ contrast\\ enhanced\\ ct\\ of\\ the\\ head\\.\ \(0\)\
\-\ \\ \\-\\ bilateral\\ basal\\ ganglia\\ and\\ cerebellar\\ calcifications\\.\ \(0\)\
\-\ \\ \\-\\ no\\ acute\\ intra\\-axial\\ pathology\\ is\\ noted\\.\ \(0\)\
\-\ fahr\\'s\\ disease\\.\ \(0\)\
\-\ fahr\\'s\\ disease\\.\ \(0\)\
\-\ normal\\ symmetric\\ basal\\ ganglia\\ calcifications\\ in\\ the\\ elderly\\.\ \(0\)\
\-\ pathologic\\ basal\\ ganglia\\ calcifications\\ from\\ endocrine\\ or\\ neuropsychiatric\\ causes\\.\ \(0\)\
\-\ 50\\ year\\ old\\ woman\\ who\\ presents\\ with\\ subacute\\ mental\\ status\\ changes\\.\ \(1\)\
\-\ fahr\\'s\\ disease\\ is\\ a\\ rare\\ degenerative\\ neurological\\ disorder\\ characterized\\ by\\ extensive\\ bilateral\\ basal\\ ganglia\\ calcifications\\ that\\ can\\ lead\\ to\\ movement\\ disorders\\ and\\ neuropsychiatric\\ manifestations\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ fahr\\:\\ 0\\.39287672958369496\ \(0\)\
\-\ ganglia\\:\\ 0\\.35001030284577034\ \(0\)\
\-\ basal\\:\\ 0\\.31866554365387023\ \(0\)\
\-\ calcifications\\:\\ 0\\.2717903792929956\ \(0\)\
\-\ neuropsychiatric\\:\\ 0\\.26786919260438563\ \(0\)\
\-\ chelators\\:\\ 0\\.14888945931873487\ \(0\)\
\-\ antagonists\\:\\ 0\\.142271827011855\ \(0\)\
\-\ non\\:\\ 0\\.13252421188963398\ \(0\)\
\-\ disease\\:\\ 0\\.11724202213066001\ \(0\)\
\-\ tremor\\:\\ 0\\.11302836040372843\ \(0\)\
\-\ resting\\:\\ 0\\.11130876200094614\ \(0\)\
\-\ who\\:\\ 0\\.10532783582085553\ \(0\)\
\-\ endocrine\\:\\ 0\\.101268262143962\ \(0\)\
\-\ bilateral\\:\\ 0\\.10007229106229042\ \(0\)\
\-\ elderly\\:\\ 0\\.09807349738718636\ \(0\)\
\-\ manifestations\\:\\ 0\\.09540288692152397\ \(0\)\
\-\ toxic\\:\\ 0\\.09509781094622523\ \(0\)\
\-\ stated\\:\\ 0\\.09207182834998666\ \(0\)\
\-\ gen\\:\\ 0\\.09182264657134112\ \(0\)\
\-\ subacute\\:\\ 0\\.08712736172759768\ \(0\)\
\-\ neuro\\:\\ 0\\.08676058023656304\ \(0\)\
\-\ older\\:\\ 0\\.08640186053352691\ \(0\)\
\-\ movement\\:\\ 0\\.08570724125873833\ \(0\)\
\-\ characterized\\:\\ 0\\.08553810928436026\ \(0\)\
\-\ lead\\:\\ 0\\.08290245783979099\ \(0\)\
\-\ vitals\\:\\ 0\\.08220187434440936\ \(0\)\
\-\ disorders\\:\\ 0\\.08220187434440936\ \(0\)\
\-\ mental\\:\\ 0\\.0811399656160747\ \(0\)\
\-\ symmetric\\:\\ 0\\.07978422822664703\ \(0\)\
\-\ degenerative\\:\\ 0\\.07908960895185843\ \(0\)\
\-\ disorder\\:\\ 0\\.07875307972059037\ \(0\)\
\-\ pe\\:\\ 0\\.07696700020971119\ \(0\)\
\-\ neurological\\:\\ 0\\.07647684056494593\ \(0\)\
\-\ cerebellar\\:\\ 0\\.07618965856081925\ \(0\)\
\-\ normal\\:\\ 0\\.07602538149876784\ \(0\)\
\-\ appearing\\:\\ 0\\.07439432410811497\ \(0\)\
\-\ stable\\:\\ 0\\.07364666257191442\ \(0\)\
\-\ pathology\\:\\ 0\\.07308793991465871\ \(0\)\
\-\ extensive\\:\\ 0\\.07173333976450763\ \(0\)\
\-\ enhanced\\:\\ 0\\.07088895719378602\ \(0\)\
\-\ causes\\:\\ 0\\.0703493679028313\ \(0\)\
\-\ rare\\:\\ 0\\.07028315649571139\ \(0\)\
\-\ developed\\:\\ 0\\.06907363365166187\ \(0\)\
\-\ appears\\:\\ 0\\.06817828544084902\ \(0\)\
\-\ reported\\:\\ 0\\.0670561192164336\ \(0\)\
\-\ 50\\:\\ 0\\.06501970077213715\ \(0\)\
\-\ status\\:\\ 0\\.06497190838228775\ \(0\)\
\-\ labs\\:\\ 0\\.064501527426351\ \(0\)\
\-\ three\\:\\ 0\\.062496957676114205\ \(0\)\
\-\ past\\:\\ 0\\.06060197164347851\ \(0\)\
\-\ age\\:\\ 0\\.058450001214749685\ \(0\)\
\-\ her\\:\\ 0\\.05816449382691512\ \(0\)\
\-\ and\\:\\ 0\\.05771481376623373\ \(0\)\
\-\ years\\:\\ 0\\.057069932519293376\ \(0\)\
\-\ changes\\:\\ 0\\.056266623631633456\ \(0\)\
\-\ the\\:\\ 0\\.055731328041139575\ \(0\)\
\-\ focal\\:\\ 0\\.05568906904944762\ \(0\)\
\-\ head\\:\\ 0\\.05552773900961211\ \(0\)\
\-\ include\\:\\ 0\\.05539450488628922\ \(0\)\
\-\ than\\:\\ 0\\.052776555275853516\ \(0\)\
\-\ mild\\:\\ 0\\.052776555275853516\ \(0\)\
\-\ over\\:\\ 0\\.05176848980686831\ \(0\)\
\-\ is\\:\\ 0\\.050992919818625464\ \(0\)\
\-\ acute\\:\\ 0\\.05036431568951802\ \(0\)\
\-\ noted\\:\\ 0\\.0493622433575248\ \(0\)\
\-\ can\\:\\ 0\\.04885668246690866\ \(0\)\
\-\ woman\\:\\ 0\\.04848753061940028\ \(0\)\
\-\ contrast\\:\\ 0\\.045236085314918344\ \(0\)\
\-\ well\\:\\ 0\\.0450801727231074\ \(0\)\
\-\ female\\:\\ 0\\.0449257354553616\ \(0\)\
\-\ presents\\:\\ 0\\.04478659488996366\ \(0\)\
\-\ treatment\\:\\ 0\\.044349152571788404\ \(0\)\
\-\ that\\:\\ 0\\.04040253039483302\ \(0\)\
\-\ by\\:\\ 0\\.03953626801565583\ \(0\)\
\-\ from\\:\\ 0\\.03697594202499578\ \(0\)\
\-\ with\\:\\ 0\\.03646084897190671\ \(0\)\
\-\ ct\\:\\ 0\\.03544458958530083\ \(0\)\
\-\ or\\:\\ 0\\.032388330678194216\ \(0\)\
\-\ no\\:\\ 0\\.03027552657698844\ \(0\)\
\-\ year\\:\\ 0\\.02869202858426871\ \(0\)\
\-\ old\\:\\ 0\\.027554279433070438\ \(0\)\
\-\ to\\:\\ 0\\.023275175325579222\ \(0\)\
\-\ in\\:\\ 0\\.023160614960831265\ \(0\)\
\-\ of\\:\\ 0\\.018219538316150932\ \(0\)\
